| Study |
Reference |
|
Anderson, 2020
|
Anderson Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects. JAMA Psychiatry 2020; 77(12):1246-1255. Nembhard Maternal and infant genetic variants, maternal periconceptional use of selective serotonin reuptake inhibitors, and risk of congenital heart defects in offspring: population based study. BMJ 2017; 356:j832
|
|
Chan (Controls exposed to SSRIs), 2024
|
Chan Prenatal antidepressant use and risk of congenital malformations: A population-based cohort study. Psychiatry Res 2024; 339:116038
|
|
Chan (Controls unexposed, pop general), 2024
|
Chan Prenatal antidepressant use and risk of congenital malformations: A population-based cohort study. Psychiatry Res 2024; 339:116038
|
|
Djulus (Controls exposed to other antidepressants), 2006
|
Djulus Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. J Clin Psychiatry 2006; 67:1280-4
|
|
Djulus (Controls unexposed, disease free), 2006
|
Djulus Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. J Clin Psychiatry 2006; 67:1280-4
|
|
Einarson, 2009
|
Einarson A Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry 2009;54:242-6
|
|
Gungor (Controls exposed to SSRI), 2019
|
Gungor, B.B. Comparison of the groups treated with mirtazapine and selective serotonine reuptake inhibitors with respect to birth outcomes and severity of psychiatric disorder Psychiatry and Clinical Psychopharmacology 2019; 29:822-.
|
|
Gungor (Controls unexposed, disease free), 2019
|
Gungor, B.B. Comparison of the groups treated with mirtazapine and selective serotonine reuptake inhibitors with respect to birth outcomes and severity of psychiatric disorder Psychiatry and Clinical Psychopharmacology 2019; 29:822-.
|
|
Gungor (Controls unexposed, sick), 2019
|
Gungor, B.B. Comparison of the groups treated with mirtazapine and selective serotonine reuptake inhibitors with respect to birth outcomes and severity of psychiatric disorder Psychiatry and Clinical Psychopharmacology 2019; 29:822-.
|
|
Heuvelman, 2023
|
Heuvelman Antidepressants in pregnancy: applying causal epidemiological methods to understand service-use outcomes in women and long-term neurodevelopmental outcomes in exposed children. Health Technol Assess 2023; 27:1-83
|
|
Källen, 2013
|
Källen B The use of central nervous system active drugs during pregnancy. Pharmaceuticals (Basel) 2013;6:1221-86
|
|
Kieler, 2015
|
Kieler Use of antidepressants and association with elective termination of pregnancy: population based case-control study. BJOG 2015; 122:1618-24
|
|
Kolding (Controls unexposed, disease free), 2021
|
Kolding Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study. BJOG 2021; 128:1949-1957
|
|
Kolding (Controls unexposed, sick), 2021
|
Kolding Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study. BJOG 2021; 128:1949-1957
|
|
Laspro, 2024
|
Laspro Association of Commonly Prescribed Antepartum Medications and Incidence of Orofacial Clefting. Cleft Palate Craniofac J 2024; :10556656241237679
|
|
Lee (Controls exposed to SSRI), 2025
|
Lee Antidepressant use during pregnancy and risk of obstetrics and neonatal outcomes: A propensity score-weighted population-based cohort study in 2003-2018. Eur Neuropsychopharmacol 2025; 96:36-45
|
|
Lee (Controls unexposed, general pop), 2025
|
Lee Antidepressant use during pregnancy and risk of obstetrics and neonatal outcomes: A propensity score-weighted population-based cohort study in 2003-2018. Eur Neuropsychopharmacol 2025; 96:36-45
|
|
Martin, 2024
|
Martin Antidepressant use during pregnancy and birth outcomes: analysis of electronic health data from the UK, Norway, and Sweden. medRxiv 2024; :
|
|
Ostenfeld, 2022
|
Ostenfeld Mirtazapine exposure in pregnancy and fetal safety: A nationwide cohort study. Acta Psychiatr Scand 2022; 145:557-567
|
|
Ozturk, 2016
|
Ozturk, Z. Safety of psychotropic medications in pregnancy: An observational cohort study Klinik Psikofarmakoloji Bulteni 2016; 26:229-.
|
|
Palmsten a (control exposed to SSRIs), 2013
|
Palmsten Antidepressant use and risk for preeclampsia. Epidemiology 2013; 24:682-91
|
|
Palmsten a (Controls unexposed, sick), 2013
|
Palmsten Antidepressant use and risk for preeclampsia. Epidemiology 2013; 24:682-91
|
|
Palmsten b, 2013
|
Palmsten Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ 2013; 347:f4877
|
|
Winterfeld (Controls exposed to SSRI), 2015
|
Winterfeld Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study. J Clin Psychopharmacol 2015; 35:250-9
|
|
Winterfeld (Controls unexposed, NOS), 2015
|
Winterfeld Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study. J Clin Psychopharmacol 2015; 35:250-9
|
|
Yaris, 2005
|
Yaris Psychotropic drugs in pregnancy: a case-control study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005; 29:333-8
|
